We are extremely happy to announce that Medsafe (New Zealand Medicines and Medical Devices Safety Authority) has approved our dossier of Tacrolimus Ointment 0.1%. This is a remarkable achievement considering the innovator has never launched this product in New Zealand so our partners will be able to create the market for Tacrolimus Ointment 0.1% from ground zero!
This MA will be commercialized by one of our partners in New Zealand.
Please contact us for further information.
